Outset Medical Inc. (NASDAQ:OM) shares fell to a low of $46.01 before closing at $48.65. Intraday shares traded counted 0.52 million, which was -1.25% lower than its 30-day average trading volume of 510.66K. OM’s previous close was $46.93 while the outstanding shares total 42.76M. The stock’s Relative Strength Index (RSI) is 48.40, with weekly volatility at 5.01% and ATR at 2.79. The OM stock’s 52-week price range has touched low of $41.07 and a $66.96 high. The stock traded higher over the last trading session, gaining 3.67% on 05/26/21.
Investors have identified the Medical Devices company Outset Medical Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $2.22 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Outset Medical Inc. (OM) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 321.73 million total, with 34.82 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -3.14 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on OM sounds very interesting.
Is the stock of OM attractive?
In related news, Chief Financial Officer, Chambers Rebecca sold 16,727 shares of the company’s stock in a transaction that recorded on May 25. The sale was performed at an average price of 45.11, for a total value of 754,535. As the sale deal closes, the General Counsel, Brottem John L. now sold 3,500 shares of the company’s stock, valued at 148,192. Also, President & CEO, Trigg Leslie sold 20,000 shares of the company’s stock in a deal that was recorded on May 03. The shares were price at an average price of 58.05 per share, with a total market value of 1,161,069. Following this completion of acquisition, the Chief Operating Officer, Vazquez Martin now holds 5,000 shares of the company’s stock, valued at 290,406. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.70%.
5 out of 7 analysts covering the stock have rated it a Buy, while 2 have maintained a Hold recommendation on Outset Medical Inc.. 0 analysts has assigned a Sell rating on the OM stock. The 12-month mean consensus price target for the company’s shares has been set at $63.17.